Search papers, labs, and topics across Lattice.
1
1
0
15
Emicizumab prophylaxis for hemophilia demonstrates comparable BMD outcomes to FVIII prophylaxis at one year, suggesting bleeding control is the primary driver of bone health, rather than the specific factor replacement strategy.
